Enlarge / NEW YORK - AUGUST 4: Shkreli was found guilty on three of the eight counts involving securities fraud and conspiracy to commit securities and wire fraud. (credit: Getty | Drew Angerer) Martin Shkreli’s former pharmaceutical company lost more than $1 million in the first quarter of 2018 amid waning sales of the drug made famous by Shkreli’s more than 5,000-percent price increase.